Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

PETNECK2 Research Team; Paul Nankivell; Piers Gaunt; Claire Gaunt; Julia Sissons; Evaggelia Liaskou; Yolande Jefferson; Tessa Fulton-Lieuw; Saloni Mittal; Hisham Mehanna

doi:10.1186/s12885-024-12639-2

Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

PETNECK2 Research Team, Paul Nankivell^*, Piers Gaunt, Claire Gaunt, Julia Sissons, Evaggelia Liaskou, Yolande Jefferson, Tessa Fulton-Lieuw, Saloni Mittal, Hisham Mehanna

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

9 Downloads (Pure)

Original language	English
Article number	861
Number of pages	2
Journal	BMC Cancer
Volume	24
Issue number	1
DOIs	https://doi.org/10.1186/s12885-024-12639-2
Publication status	Published - 18 Jul 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12885-024-12639-2Licence: Creative Commons: Attribution (CC BY)

NankivellP2024CorrectionFinal published version, 654 KBLicence: Creative Commons: Attribution (CC BY)

Cite this

PETNECK2 Research Team, Nankivell, P., Gaunt, P., Gaunt, C., Sissons, J., Liaskou, E., Jefferson, Y., Fulton-Lieuw, T., Mittal, S., & Mehanna, H. (2024). Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial. BMC Cancer, 24(1), Article 861. https://doi.org/10.1186/s12885-024-12639-2

@article{b6ea078ecb9e499f84700f82ec8a3f7b,

title = "Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial",

author = "{PETNECK2 Research Team} and Paul Nankivell and Piers Gaunt and Claire Gaunt and Julia Sissons and Evaggelia Liaskou and Yolande Jefferson and Tessa Fulton-Lieuw and Saloni Mittal and Hisham Mehanna",

year = "2024",

month = jul,

day = "18",

doi = "10.1186/s12885-024-12639-2",

language = "English",

volume = "24",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "Springer",

number = "1",

}

PETNECK2 Research Team, Nankivell, P , Gaunt, P, Gaunt, C, Sissons, J, Liaskou, E, Jefferson, Y, Fulton-Lieuw, T, Mittal, S & Mehanna, H 2024, 'Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial', BMC Cancer, vol. 24, no. 1, 861. https://doi.org/10.1186/s12885-024-12639-2

Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial. / PETNECK2 Research Team ; Nankivell, Paul ; Gaunt, Piers et al.
In: BMC Cancer, Vol. 24, No. 1, 861, 18.07.2024.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction

T2 - PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

AU - PETNECK2 Research Team

AU - Nankivell, Paul

AU - Gaunt, Piers

AU - Gaunt, Claire

AU - Sissons, Julia

AU - Liaskou, Evaggelia

AU - Jefferson, Yolande

AU - Fulton-Lieuw, Tessa

AU - Mittal, Saloni

AU - Mehanna, Hisham

PY - 2024/7/18

Y1 - 2024/7/18

U2 - 10.1186/s12885-024-12639-2

DO - 10.1186/s12885-024-12639-2

M3 - Comment/debate

SN - 1471-2407

VL - 24

JO - BMC Cancer

JF - BMC Cancer

IS - 1

M1 - 861

ER -

PETNECK2 Research Team, Nankivell P , Gaunt P, Gaunt C, Sissons J, Liaskou E et al. Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial. BMC Cancer. 2024 Jul 18;24(1):861. doi: 10.1186/s12885-024-12639-2